Monday - April 13, 2026

Category Archives: Science

Motor Neuron Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 180+ Key Companies | DelveInsight

DelveInsight’s, “Motor Neuron Disease Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Motor Neuron Disease pipeline landscape. It covers the Motor Neuron Disease pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Melanoma Clinical Trial Pipeline Gains Momentum: 150+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Melanoma Pipeline Insights 2026” report provides comprehensive insights about 150+ companies and 170+ pipeline drugs in the Melanoma Pipeline landscape. It covers the Melanoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Melanoma pipeline … Continue reading →

Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Chronic and Acute Pain Pipeline Insight, 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Chronic and Acute Pain pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Severe Hypertriglyceridemia Clinical Trial Pipeline Expands as 8+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Severe Hypertriglyceridemia Pipeline Insight, 2026” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Severe Hypertriglyceridemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment … Continue reading →

Non-Hodgkin Lymphoma Treatment Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Non-Hodgkin Lymphoma Pipeline Insight, 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Non-Hodgkin Lymphoma pipeline landscape. It covers the Non-Hodgkin Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Aurora Compounding Pharmacy Helps Patients Across Canada Access Customised Compounded Therapies With Trusted Oversight

Professional portrait of Michael Khalil, B.Sc.Pharm, RPh, Chief Pharmacist at Aurora Compounding Pharmacy in Toronto, Ontario. With more than 30 years of experience in pharmacy practice, Michael Khalil focuses on custom compounding, personalised medication preparation, and pharmacist-guided care. He is … Continue reading →

Exosomes Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Exosomes Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Exosomes pipeline landscape. It covers the Exosomes Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Exosomes Pipeline … Continue reading →

Dilated Cardiomyopathy Clinical Trial Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Dilated Cardiomyopathy Pipeline Insight 2026” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Dilated Cardiomyopathy pipeline landscape. It covers the Dilated Cardiomyopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Glioma Clinical Trial Pipeline Appears Robust With 180+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Glioma Pipeline Insight, 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the glioma pipeline landscape. It covers the Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioma therapeutics … Continue reading →

COVID-19 Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “COVID-19 Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in COVID-19 pipeline landscape. It covers the COVID-19 pipeline drug profiles, including clinical and nonclinical stage products. It also covers the COVID-19 therapeutics assessment … Continue reading →